Inside the Clinic: A Team-Based Approach to Management of GVHD

A multidisciplinary team from Dana-Farber Cancer Institute discusses their approach to the care of patients with graft versus host disease.

EP. 11: Chronic GVHD Incidence and Risk Factors

September 4th 2023

Dr Gooptu discusses the incidence of chronic GVHD and ruminates on how a patient’s medical history may impact their chronic GVHD risk.

EP. 12: Challenges with Early Diagnosis of GVHD

September 4th 2023

Mahasweta Gooptu, MD shares insights on the early identification and diagnosis of chronic GVHD.

EP. 13: Frontline Treatment of Chronic GVHD

September 11th 2023

The panel provides an overview of the frontline treatments available for chronic GVHD.

EP. 14: Steroid Administration for Chronic GVHD

September 11th 2023

Details of steroid use for chronic GVHD, including taper and response criteria, are described by the panel.

EP. 15: The Steroid-Refractory Chronic GVHD Landscape

September 18th 2023

GVHD experts outline the treatment options for patients with steroid-refractory chronic GVHD.

EP. 16: Selecting Therapy for Steroid-Refractory Chronic GVHD

September 18th 2023

Dr Gooptu highlights how she selects therapy for a patient who is refractory to steroids for chronic GVHD and Dr Inyang notes the adverse events seen with these therapies.

EP. 17: Monitoring and Follow-Up of Patients with Chronic GVHD

September 25th 2023

The panel closes by reviewing the patient case once more and shares clinical pearls on the treatment of patients with GVHD.